Weill Cornell/Rockefeller/Sloan Kettering MST Program

威尔康奈尔/洛克菲勒/斯隆凯特林 MST 计划

• 批准号: 10197139
• 负责人: KATHARINE C HSU
• 金额: $ 263.44万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 1979
• 资助国家: 美国
• 起止时间: 1979-07-01 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10197139
• 关键词: programs

PROJECT SUMMARY The Tri-Institutional MD-PhD Program is a joint undertaking of Weill Cornell Medicine (WCM), The Rockefeller University (RU), and the Sloan Kettering Institute for Cancer Research (SKI). Its mission is to train biomedical investigators who: on the one hand, have advanced understanding of biomedical science and a mastery of contemporary research skills, which will allow them to undertake fundamental studies to elucidate basic biological processes pertaining to human disease; and, on the other hand, are well grounded in human biology, pathobiology and clinical medicine, which will equip them to transfer advances in basic research to the understanding, prevention, and treatment of human disease. The three institutions operate three graduate schools: Weill Cornell Graduate School of Medical Sciences (WCGS), a joint undertaking between WCM and SKI; the David Rockefeller Graduate School at RU; and the Gerstner Graduate School of Biomedical Sciences (GSK) at SKI. The Tri-Institutional MD-PhD Program was formed in 1991, when two independent MD-PhD Programs, the WCM-RU Program and the WCM-WCGS Program, were joined to form the present program. GSK became part of the Program in 2009. MSTP trainees complete all requirements for the MD degree at WCM. They receive their PhD training in research laboratories in the three research institutions and receive their PhD degree from GSK, RU or WCGS. Accepted trainees arrive in early July before the start of medical school. During the first two years in the Program they complete their medical school course, take two graduate level courses designed for MD-PhD students, and complete three research rotations (in three different laboratories) before they settle into their thesis laboratory. When the students choose a research laboratory they enroll in the graduate school with which their thesis mentor is associated. The graduate course and thesis requirements are comparable for all MD-PhD students, irrespective of the graduate school in which they are matriculated—and the students can cross register and take courses for credit in any of the graduate schools. At the end of their research training, after they have defended their thesis, the students return to complete their clinical training at WMC. The present application requests funds to continue MD-PhD training at the three institutions beyond Year 45 (the predecessor WCMC-RU Program was formed in 1972; it received NIH funding in 1974). In its current iteration, the Program brings together faculty in more than 250 independent research laboratories. 379 MD- PhDs have graduated from the Tri-Institutional MD-PhD Program and its predecessors; currently there are 137 students in the Program. The current trainees come from 55 undergraduate schools. Their average GPA is 3.75. 94% of the graduates pursue post-graduate clinical training; of the 305 graduates who have completed their training, 258 (85%) have appointments in medical schools, research institutes or biotech/pharma.

项目摘要 三机构MD-PHD计划是洛克菲勒的Weill Cornell Medicine（WCM）的联合承诺 大学（RU）和Sloan Kettering癌症研究所（SKI）。它的任务是培训生物医学 一方面，对生物医学科学有深入了解的调查人员 当代研究技能，这将使他们能够进行基础研究以阐明基本 与人类疾病有关的生物过程；另一方面，在人类生物学中良好的基础， 病理生物学和临床医学，这将使他们能够将基础研究的进步转移到 了解人类疾病的理解，预防和治疗。 这三个机构经营三所研究生院：威尔·康奈尔医学科学研究生院 （WCGS），WCM和滑雪之间的联合事务； Ru的David Rockefeller研究生院；和 Gerstner生物医学科学研究生院（GSK）。三机构的MD-PHD计划是 成立于1991年，当时两个独立的MD-PHD程序，WCM-RU程序和WCM-WCGS 计划加入以组成当前程序。 GSK于2009年成为该计划的一部分。 MSTP受训者在WCM上完成了MD学位的所有要求。他们接受了博士学位培训 三个研究机构的研究实验室，并从GSK，RU或WCG获得博士学位。 公认的学员在医学院开始之前的7月初到达。在头两年中 他们完成医学院课程的计划，参加为MD-PHD设计的两个研究生级课程 学生，并在安顿下来之前完成三个研究轮换（三个不同的实验室） 论文实验室。当学生选择研究实验室时，他们就读于研究生院 他们的论文的心理与之相关。所有人的研究生课程和论文要求都相当 MD-PHD学生，无论他们在该研究生院的毕业生，学生都可以 交叉注册并在任何研究生院学习学分。在他们的研究培训结束时， 在定义论文之后，学生返回在WMC完成临床培训。 本申请要求资金以超过一年的三个机构继续MD-PHD培训 45（前身WCMC-RU计划成立于1972年； 1974年获得了NIH资金）。目前 该计划的迭代汇集了250多个独立研究实验室的教师。 379 MD- 博士学位已从三机构MD-PHD计划及其前身毕业；目前有137 该计划的学生。目前的学员来自55所本科学校。他们的平均GPA是 3.75。 94％的毕业生接受研究生临床培训；完成的305名毕业生 他们的培训为258（85％）在医学院，研究机构或生物技术/制药公司任命。